---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-040725"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2024-10-10T23:59:59+00:00"
generated_at: "2026-05-30T16:52:47.098384+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# PowerUp extends Aspire merger disclosure schedule delivery to Oct 11, 2024

## Summary
- Second Amendment Agreement moves Disclosure Schedule Delivery Date to October 11, 2024.
- Allows additional time for due diligence and compilation of disclosure schedules.
- No changes to merger consideration, equity incentive pool, or other key terms.
- Amendment is in connection with the previously announced business combination with Aspire Biopharma.

## SEC filing metadata
- accession: 0001493152-24-040725
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2024-10-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315224040725/0001493152-24-040725-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315224040725/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-040725
- JSON: https://secwatch.observer/filing/0001493152-24-040725.json
- Plain text: https://secwatch.observer/filing/0001493152-24-040725.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.